Cargando…

Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease

Alcoholic liver disease (ALD) is one of the leading causes of morbidity among adults with alcohol use disorder (AUD) worldwide. Its clinical course ranges from steatosis to alcoholic hepatitis, progressing to more severe forms of liver damage, such as cirrhosis and hepatocellular carcinoma. The path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuenzalida, Catalina, Dufeu, María Soledad, Poniachik, Jaime, Roblero, Juan Pablo, Valenzuela-Pérez, Lucía, Beltrán, Caroll Jenny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497569/ https://www.ncbi.nlm.nih.gov/pubmed/34630107 http://dx.doi.org/10.3389/fphar.2021.729950

Ejemplares similares

The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022)

Harnessing the potential of probiotics in the treatment of alcoholic liver disorders
por: Mishra, Garima, et al.
Publicado: (2023)

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
por: De Ternay, Julia, et al.
Publicado: (2019)

Socioeconomic inequalities in the incidence of alcohol-related liver disease in the Latin American context
por: Roblero, Juan Pablo, et al.
Publicado: (2021)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

Probiotics for Alleviating Alcoholic Liver Injury
por: Gu, Zelin, et al.
Publicado: (2019)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
por: Pi, Aiwen, et al.
Publicado: (2021)

Targeting glutamate uptake to treat alcohol use disorders
por: Rao, P.S.S., et al.
Publicado: (2015)

Zebrafish as a Model for Fetal Alcohol Spectrum Disorders
por: Alsakran, Amena, et al.
Publicado: (2021)

Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction
por: Cao, Yuhan, et al.
Publicado: (2022)

Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy
por: Li, Songtao, et al.
Publicado: (2022)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?
por: Yan, Junbin, et al.
Publicado: (2021)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease
por: Tang, Xiao-Han, et al.
Publicado: (2021)

Mephedrone and Alcohol Interactions in Humans
por: Papaseit, Esther, et al.
Publicado: (2020)

Roxadustat, a Hypoxia-Inducible Factor 1α Activator, Attenuates Both Long- and Short-Term Alcohol-Induced Alcoholic Liver Disease
por: Gao, Yongyao, et al.
Publicado: (2022)

Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders
por: Vadnie, Chelsea A., et al.
Publicado: (2014)

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Wu, Jingyi, et al.
Publicado: (2023)

Jia-ga-song-tang protection against alcoholic liver and intestinal damage
por: Fang, Jiamin, et al.
Publicado: (2022)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
por: Ibrahim, Islam A. A. E. H., et al.
Publicado: (2023)

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
por: Li, Fengyuan, et al.
Publicado: (2016)

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Frontiers Production Office,
Publicado: (2023)

Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
por: Gutridge, Anna M., et al.
Publicado: (2021)

The role of the type 7 adenylyl cyclase isoform in alcohol use disorder and depression
por: Tabakoff, Boris, et al.
Publicado: (2022)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

Bmal1 Regulates Macrophage Polarize Through Glycolytic Pathway in Alcoholic Liver Disease
por: Zhou, Yiwen, et al.
Publicado: (2021)

Identifying Candidate Flavonoids for Non-Alcoholic Fatty Liver Disease by Network-Based Strategy
por: Lee, Won-Yung, et al.
Publicado: (2022)

Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms
por: Ye, Shujun, et al.
Publicado: (2022)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk
por: Zhu, Lin, et al.
Publicado: (2023)

The Kynurenine Pathway and Mediating Role of Stress in Addictive Disorders: A Focus on Alcohol Use Disorder and Internet Gaming Disorder
por: Jang, Joon Hwan, et al.
Publicado: (2022)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Editorial: Adolescent brain and alcohol
por: Pandey, Subhash C., et al.
Publicado: (2022)

Multiple Sessions of Transcranial Direct Current Stimulation (tDCS) Reduced Craving and Relapses for Alcohol Use: A Randomized Placebo-Controlled Trial in Alcohol Use Disorder
por: Klauss, Jaisa, et al.
Publicado: (2018)

Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control
por: Gál, Bernadett I., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1k5lcpb0u1bfv3gf8mb0fds2al